For instance, CTBP2 was demonstrated to facilitate the development of ESCC [27] and breast cancer [42] through negatively regulating p16 (INK4A), a tumor suppressor gene product. This evidence concerns the gene CDKN2A and esophageal squamous cell carcinoma.